As of 3:59pm ET
| -0.07 / -0.94%|
The 8 analysts offering 12-month price forecasts for ARIAD Pharmaceuticals Inc have a median target of 9.50, with a high estimate of 13.00 and a low estimate of 6.00. The median estimate represents a +28.55% increase from the last price of 7.39.
The current consensus among 8 polled investment analysts is to Buy stock in ARIAD Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.